330 filings
Page 8 of 17
S-8
9ohfkcib6mlm109d
13 Sep 19
Registration of securities for employees
5:15pm
SUPPL
aesofesiih3 6n0d4g
13 Sep 19
Supplemental materials (foreign)
5:05pm
6-K
ws54pz 2q2mel
6 Aug 19
Current report (foreign)
4:06pm
6-K
tgy523i2borgjk8u w3h
6 Aug 19
Aurinia Pharmaceuticals Inc. 6-K
4:02pm
6-K
kwi x9id8f
18 Jul 19
Aurinia Pharmaceuticals Inc. 6-K
6:30am
6-K
kcfnys9 g21so
27 Jun 19
Dissident Withdraws the Consents of its Nominees from Consideration Prior to the AGM
12:00am
6-K
2ectqyjrs86x 6d
21 Jun 19
Shareholders can vote the YELLOW proxy even if they previously voted on the green proxy
6:30am
6-K
gnnv7tn
19 Jun 19
Leading Independent Proxy Advisors Recommend Aurinia Shareholders Vote the YELLOW Proxy Card FOR All of Aurinia’s Director Nominees
6:30am
6-K
gld14t9 rq
7 Jun 19
Aurinia Issues Letter to Shareholders
8:00am
6-K
p70xedw85xhpw
31 May 19
Aurinia Pharmaceuticals Announces Upcoming Annual General Meeting of Shareholders
8:30am
6-K
ebfpzsr
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
6-K
1y59 fkhy0c4
14 May 19
Current report (foreign)
4:04pm
6-K
n2jdwapx
14 May 19
Aurinia Reports First Quarter 2019 Financial Results and Recent Operational Highlights
4:02pm
6-K
qcpr3qyzd 97
10 May 19
Aurinia Pharmaceuticals Inc. 6-K
7:00am
6-K
7xut nqg6xpue1oopu
30 Apr 19
Aurinia Further Strengthens Its Board of Directors with the Appointment of Dr. Daniel Billen
6:05am
6-K
cr39zr gsu
11 Apr 19
Aurinia Pharmaceuticals Inc. 6-K
4:39pm
40-F
mynpzg 6ihr
19 Mar 19
Annual report (Canada)
4:16pm
6-K
y16 k2jwbvzmi
19 Mar 19
Aurinia Reports Fourth Quarter and Full Year 2018 Financial Results and Operational Highlights
4:02pm
6-K
witka13f
14 Mar 19
Aurinia Recognizes World Kidney Day and National Kidney Month with New Activities Focused on Raising Awareness for Kidney Disease
7:00am
6-K
znz9r1hf
27 Feb 19
Aurinia Closes At-The-Market Facility
6:30am